TEOSYAL RHA® 1 for Neck Lines, Perioral Lines and Smiling Lines

Exclusion Criteria

• •1. Minor subjects
• •2. Subjects who already had fillers and/or other skin quality treatment(s) in the 6 months preceding the study.
• •3. Subjects undergoing or planning to undergo peeling treatment or laser/ultrasound-based treatment during the study or having had one of these treatments in the 6 months preceding the study.
• •4. Subjects showing cutaneous disorders, inflammation or infection (acne, herpes, scars…) at the treatment site or near to this site.
• •5. Subjects having a known hypersensibility to lidocaine and/or amide local anesthetic agents or hyaluronic acid, or with history of severe allergy or anaphylactic shock.
• •6. Subjects with autoimmune or cardiac diseases and/or undergoing treatment for heart diseases (beta blockers).
• •7. Subjects with hepatocellular insufficiency and/or undergoing treatment for liver disease.
• •8. Subjects suffering from epilepsy or porphyria.
• •9. Subjects with severe, ongoing and/or uncontrolled disease that may pose a health risk to the subject during the study and/or may have an impact on the study assessments.
• •10. Subjects receiving or planning to receive high dose Vitamin E, aspirin, anti-inflammatories, or anti-coagulant during the week preceding each injection.
• •11. Subjects receiving any long-term medical treatment or any treatment that, in the opinion of the clinical investigator, may interfere with test results or put the subject at undue risk.
• •12. Subjects under guardianship/tutorship.
• •13. Pregnant women or breastfeeding mother.
• •14. Subjects participating to another research on human beings or being in an exclusion period for a previous study.